BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
5-HT1-like receptor agonists as migraine treatment from Merck & Co.
July 19, 1996
BTG-2403: representative opioid analgesic
July 19, 1996
Glaxo Wellcome's Ultiva receives FDA approval
July 19, 1996
NOS inhibitors from Merck & Co.
July 12, 1996
TNF research findings
July 12, 1996
Muscarinic receptor ligand selected for further study
July 12, 1996
First demonstration of cellular mechanism of human oral tolerance
July 12, 1996
First approval of SmithKline Beecham's ReQuip in U.K.
July 12, 1996
Lundbeck's Serdolect reaches first market
July 12, 1996
Pharmacia & Upjohn's dopamine D4 receptor ligands
July 12, 1996
Previous
1
2
…
2767
2768
2769
2770
2771
2772
2773
2774
2775
…
2796
2797
Next
RSS